Inventiva (IVA) Stock Forecast, Price Target & Predictions
IVA Stock Forecast
Inventiva stock forecast is as follows: a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
IVA Analyst Ratings
According to 3 Wall Street analysts, Inventiva's rating consensus is 'Buy'. The analyst rating breakdown for IVA stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 26, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 20, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Apr 08, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| May 19, 2023 | Societe Generale | - | Buy | Upgrade |
Inventiva's last stock rating was published by H.C. Wainwright on Sep 26, 2024. The company gave IVA a "Buy" rating, the same as its previous rate.
Inventiva Financial Forecast
Inventiva Revenue Forecast
| Mar 28 | Dec 27 | Jun 27 | Mar 27 | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $3.74M | $3.74M | $66.60M | $13.98M | $1.15M | $3.20M | $4.54M | $3.77M | $3.77M | $3.59M | $1.20M | $2.56M | $18.27M | $1.37M |
| High Forecast | $3.74M | $3.74M | $66.60M | $13.98M | $1.15M | $3.20M | $4.54M | $3.77M | $3.77M | $3.59M | $1.20M | $2.56M | $18.27M | $1.37M |
| Low Forecast | $3.74M | $3.74M | $66.60M | $13.98M | $1.15M | $3.20M | $4.54M | $3.77M | $3.77M | $3.59M | $1.20M | $2.56M | $18.27M | $1.37M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Inventiva's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. IVA's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Inventiva EBITDA Forecast
| Mar 28 | Dec 27 | Jun 27 | Mar 27 | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-3.74M | $-3.74M | $-66.60M | $-13.98M | $-1.15M | $-3.20M | $-4.54M | $-3.77M | $-3.77M | $-3.59M | $-1.20M | $-2.56M | $-18.27M | $-1.37M |
| High Forecast | $-3.74M | $-3.74M | $-66.60M | $-13.98M | $-1.15M | $-3.20M | $-4.54M | $-3.77M | $-3.77M | $-3.59M | $-1.20M | $-2.56M | $-18.27M | $-1.37M |
| Low Forecast | $-3.74M | $-3.74M | $-66.60M | $-13.98M | $-1.15M | $-3.20M | $-4.54M | $-3.77M | $-3.77M | $-3.59M | $-1.20M | $-2.56M | $-18.27M | $-1.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
undefined analysts predict IVA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Inventiva's previous annual EBITDA (undefined) of $NaN.
Inventiva Net Income Forecast
| Mar 28 | Dec 27 | Jun 27 | Mar 27 | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-47.56M | - | $-58.83M | $-37.46M | $-40.21M | $-39.83M | $-36.48M | $-30.64M | $-30.64M | $-49.92M | $-35.11M | $-35.50M | $70.63M | $-17.84M |
| High Forecast | $-47.56M | - | $-58.83M | $-37.46M | $-40.21M | $-39.83M | $-36.48M | $-30.64M | $-30.64M | $-49.92M | $-35.11M | $-35.50M | $70.63M | $-17.84M |
| Low Forecast | $-47.56M | - | $-58.83M | $-37.46M | $-40.21M | $-39.83M | $-36.48M | $-30.64M | $-30.64M | $-49.92M | $-35.11M | $-35.50M | $70.63M | $-17.84M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Inventiva's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IVA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Inventiva SG&A Forecast
| Mar 28 | Dec 27 | Jun 27 | Mar 27 | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $22.22M | $22.22M | $395.55M | $83.02M | $6.84M | $19.02M | $26.99M | $22.41M | $22.57M | $21.34M | $7.10M | $15.22M | $108.52M | $8.16M |
| High Forecast | $22.22M | $22.22M | $395.55M | $83.02M | $6.84M | $19.02M | $26.99M | $22.41M | $22.57M | $21.34M | $7.10M | $15.22M | $108.52M | $8.16M |
| Low Forecast | $22.22M | $22.22M | $395.55M | $83.02M | $6.84M | $19.02M | $26.99M | $22.41M | $22.57M | $21.34M | $7.10M | $15.22M | $108.52M | $8.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Inventiva's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to IVA last annual SG&A of $NaN (undefined).
Inventiva EPS Forecast
| Mar 28 | Dec 27 | Jun 27 | Mar 27 | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.98 | - | $-1.21 | $-0.77 | $-0.83 | $-0.82 | $-0.75 | $-0.63 | $-0.63 | $-1.03 | $-0.72 | $-0.73 | $1.45 | $-0.37 |
| High Forecast | $-0.98 | - | $-1.21 | $-0.77 | $-0.83 | $-0.82 | $-0.75 | $-0.63 | $-0.63 | $-1.03 | $-0.72 | $-0.73 | $1.45 | $-0.37 |
| Low Forecast | $-0.98 | - | $-1.21 | $-0.77 | $-0.83 | $-0.82 | $-0.75 | $-0.63 | $-0.63 | $-1.03 | $-0.72 | $-0.73 | $1.45 | $-0.37 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Inventiva's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IVA previous annual EPS of $NaN (undefined).
Inventiva Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| VTYX | Ventyx Biosciences | $1.73 | $33.86 | 1857.23% | Buy |
| IVA | Inventiva | $2.66 | $36.00 | 1253.38% | Buy |
| VRCA | Verrica Pharmaceuticals | $0.99 | $12.00 | 1112.12% | Buy |
| IPHA | Innate Pharma | $1.70 | $10.00 | 488.24% | Buy |
| ANEB | Anebulo Pharmaceuticals | $1.50 | $6.00 | 300.00% | Buy |
| VIGL | Vigil Neuroscience | $3.00 | $11.00 | 266.67% | Buy |
| CMPX | Compass Therapeutics | $1.38 | $5.00 | 262.32% | Buy |
| RZLT | Rezolute | $4.86 | $13.50 | 177.78% | Buy |
| CGEM | Cullinan Oncology | $12.22 | $31.50 | 157.77% | Buy |
| ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
| MLYS | Mineralys Therapeutics | $11.87 | $30.00 | 152.74% | Buy |
| IMCR | Immunocore | $32.12 | $70.75 | 120.27% | Buy |
| NAMS | NewAmsterdam Pharma Company | $20.12 | $36.50 | 81.41% | Buy |
| EWTX | Edgewise Therapeutics | $31.98 | $45.00 | 40.71% | Buy |
| PCVX | Vaxcyte | $88.39 | $124.00 | 40.29% | Buy |
| JANX | Janux Therapeutics | $46.50 | $61.20 | 31.61% | Buy |
| DICE | DICE Therapeutics | $47.55 | $60.00 | 26.18% | Buy |
| ACLX | Arcellx | $87.22 | $83.00 | -4.84% | Buy |